Page last updated: 2024-08-22

n-methylaspartate and s18986-1

n-methylaspartate has been researched along with s18986-1 in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Baud, O; Destot-Wong, KD; Favrais, G; Gressens, P; Gupta, SK; Lelièvre, V; Liang, K; Mani, S; Pansiot, J; Schwendimann, L; Spedding, M1

Other Studies

1 other study(ies) available for n-methylaspartate and s18986-1

ArticleYear
The AMPA receptor positive allosteric modulator, S18986, is neuroprotective against neonatal excitotoxic and inflammatory brain damage through BDNF synthesis.
    Neuropharmacology, 2009, Volume: 57, Issue:3

    Topics: Animals; Animals, Newborn; Apoptosis; Benzothiadiazines; Brain; Brain Diseases; Brain-Derived Neurotrophic Factor; Dose-Response Relationship, Drug; Extracellular Signal-Regulated MAP Kinases; Female; Male; Mice; N-Methylaspartate; Necrosis; Neuroprotective Agents; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Receptors, AMPA; Receptors, Kainic Acid; Receptors, N-Methyl-D-Aspartate; Time Factors

2009